RESULTS OF PART LARYNGECTOMY IN TREATMENT OF LARYNGEAL CANCER AT UNIVERSITY MEDICAL HCMC FROM 2018 TO 2021

Thị Thùy Linh Võ1,, Hữu Dũng Nguyễn2, Xuân Quang Lý 3
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Cho Ray hospital
3 University of Medicine and Pharmacy at Ho Chi Minh City hospital

Main Article Content

Abstract

Background: Laryngeal cancer is a common type of head and neck cancer. The success of laryngeal preservation methods in partial laryngectomy for laryngeal cancer treatment is not only meaningful in the resolution of the disease, but also in preserving laryngeal function and improving the quality of life of patients. Objectives: Survey on surgical outcomes of patients with laryngeal cancer after partial laryngectomy and find out some factors related to surgical results. Method: The study was carried out on 38 laryngeal cancer patients undergoing partial laryngectomy at the University Medical Center HCMC from January 1, 2018 to December 31, 2021 and monitor the patient's recurrence and death. Result: The majority were male, accounting for 92.1% with the mean age of 63.0 ± 8.8 years. Surgical methods including oral laser microsurgery were 13.2%, partial laryngectomy was 86.8%. The mean postoperative hospital stay was 7.4 ± 4.4 days. The laser microsurgery group had a shorter postoperative hospital stay than the open surgery group with p < 0.005. The most postoperative complications were pneumothorax 13.1%, pneumonia was 7.9%; surgical site effusion and wound infection were 5.3%; Throat fistula, bleeding and bronchitis were all 2.6%. The results of distant follow-up showed that the recurrence rate was 7.9%. 100% of patients survived, no patients died. The mean disease-free survival time was 3.7 years, the disease-free survival rate after 3 years was 90.8%. The mean disease-free survival time of the N0 group was longer than that of the N1 group, the stage I and II groups were statistically significantly longer than the stage III with p < 0.05. Conclusion: Partial laryngectomy to treat early laryngeal cancer is safe and effective, helping patients to preserve the larynx while still achieving the goal of treatment.

Article Details

References

1. International Agency for Research on cancer. The Global Cancer Observatory Globocan 2020. World. 2021:1-2.
2. International Agency for Research on cancer. The Global Cancer Observatory Globocan 2020. Viet Nam. 2021:1-2.
3. American cancer society. Survival Rates for Laryngeal and Hypopharyngeal Cancers. https://www.cancer.org/cancer/laryngeal-and-hypopharyngeal-cancer/detection-diagnosis-staging/survival-rates.html
4. Đoàn Thị Hồng Nhật, Lê Minh Kỳ. Nhận xét két quả phẫu thuật cắt thanh quản bán phần trên nhẫn tạo hình kiểu Tucker. Tạp chí Tai Mũi Họng Việt Nam.2018; 2(63-40):72-79.
5. Pecorari G, Perottino F, Riva G, et al. Pignat's vertical partial laryngectomy with crico-hyoido-epiglotto-plasty. Eur Arch Otorhinolaryngol. 2022 Feb;279(2):979-986. doi: 10.1007/s00405-021-06858-7.
6. Bui AT, Yong Ji KS, Pham CT, et al. Longitudinal evaluation of quality of life in Laryngeal Cancer patients treated with surgery. Int J Surg. 2018 Oct; 58:65-70. doi: 10.1016/j.ijsu.2018.09.011.
7. Gökmen MF, Büyükatalay ZÇ, Beton S, Gökcan MK, Dursun G, Meço C, Küçük TB. Functional and Oncological Outcomes of Open Partial Laryngectomy vs. Transoral Laser Surgery in Supraglottic Larynx Cancer. Turk Arch Otorhinolaryngol. 2020 Dec;58(4):227-233. doi: 10.5152/tao.2020.5573.
8. Dinescu FV, Ţiple C, Chirilă M, et al. Evaluation of health-related quality of life with EORTC QLQ-C30 and QLQ-H&N35 in Romanian laryngeal cancer patients. Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2735-40. doi: 10.1007/s00405-015-3809-0.
9. Xu W, Lyu ZH, Ma JK, et al. The oncologic and functional outcomes of supracricoid partial laryngectomy for the treatment of laryngeal cancer. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 May 7;54(5):339-342. Chinese. doi: 10.3760/cma.j.issn.1673-0860.2019.05.005.
10. Muscatello L, Piazza C, Peretti G, et al. Open partial horizontal laryngectomy and adjuvant (chemo)radiotherapy for laryngeal squamous cell carcinoma: results from a multicenter Italian experience. Eur Arch Otorhinolaryngol. 2021 Oct;278(10):4059-4065. doi: 10.1007/s00405-021-06651-6.